लोड हो रहा है...
Targeting the orphan nuclear receptor NR2F6 in T cells primes tumors for immune checkpoint therapy
BACKGROUND: NR2F6 has been proposed as an alternative cancer immune checkpoint in the effector T cell compartment. However, a realistic assessment of the in vivo therapeutic potential of NR2F6 requires acute depletion. METHODS: Employing primary T cells isolated from Cas9-transgenic mice for electro...
में बचाया:
| में प्रकाशित: | Cell Commun Signal |
|---|---|
| मुख्य लेखकों: | , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BioMed Central
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6961368/ https://ncbi.nlm.nih.gov/pubmed/31937317 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12964-019-0454-z |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|